Interest in psychedelics is booming. Compelling clinical trial results and changing regulation are opening vast opportunities. It is critical that money flowing into psychedelics is responsibly invested and that natural products come to market.
Filament will be the first publicly traded psychedelics fund. Our mission is to see safe natural psychedelics in the hands of everyone who needs them as soon as possible. We will use the public markets to acquire, manage, and fund businesses that form a closely networked backbone of a thriving and safe natural psychedelics ecosystem.
The materials on this website are for illustration and discussion purposes only and do not constitute an offering.Contact: email@example.com